Diabetes Software Market Report – Research, Industry Analysis Reports and Market Demands

Global Diabetes Software Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Request for Sample of this report

Buy now

Table of Content

1 Market Overview

1.1 Product Overview and Scope of Diabetes Software
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Diabetes Software by Type
- 1.3.1 Overview: Global Diabetes Software Market Size by Type: 2019 Versus 2023 Versus 2030
- 1.3.2 Global Diabetes Software Consumption Value Market Share by Type in 2023
- 1.3.3 For Smartphones
- 1.3.4 For Tablet PC
- 1.3.5 Web-based
1.4 Global Diabetes Software Market by Application
- 1.4.1 Overview: Global Diabetes Software Market Size by Application: 2019 Versus 2023 Versus 2030
- 1.4.2 Type 1 Diabetes
- 1.4.3 Type 2 Diabetes
1.5 Global Diabetes Software Market Size & Forecast
1.6 Global Diabetes Software Market Size and Forecast by Region
- 1.6.1 Global Diabetes Software Market Size by Region: 2019 VS 2023 VS 2030
- 1.6.2 Global Diabetes Software Market Size by Region, (2019-2030)
- 1.6.3 North America Diabetes Software Market Size and Prospect (2019-2030)
- 1.6.4 Europe Diabetes Software Market Size and Prospect (2019-2030)
- 1.6.5 Asia-Pacific Diabetes Software Market Size and Prospect (2019-2030)
- 1.6.6 South America Diabetes Software Market Size and Prospect (2019-2030)
- 1.6.7 Middle East and Africa Diabetes Software Market Size and Prospect (2019-2030)

2 Company Profiles

3 Market Competition, by Players

3.1 Global Diabetes Software Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
- 3.2.1 Market Share of Diabetes Software by Company Revenue
- 3.2.2 Top 3 Diabetes Software Players Market Share in 2023
- 3.2.3 Top 6 Diabetes Software Players Market Share in 2023
3.3 Diabetes Software Market: Overall Company Footprint Analysis
- 3.3.1 Diabetes Software Market: Region Footprint
- 3.3.2 Diabetes Software Market: Company Product Type Footprint
- 3.3.3 Diabetes Software Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

4.1 Global Diabetes Software Consumption Value and Market Share by Type (2019-2024)
4.2 Global Diabetes Software Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

5.1 Global Diabetes Software Consumption Value Market Share by Application (2019-2024)
5.2 Global Diabetes Software Market Forecast by Application (2025-2030)

6 North America

6.1 North America Diabetes Software Consumption Value by Type (2019-2030)
6.2 North America Diabetes Software Consumption Value by Application (2019-2030)
6.3 North America Diabetes Software Market Size by Country
- 6.3.1 North America Diabetes Software Consumption Value by Country (2019-2030)
- 6.3.2 United States Diabetes Software Market Size and Forecast (2019-2030)
- 6.3.3 Canada Diabetes Software Market Size and Forecast (2019-2030)
- 6.3.4 Mexico Diabetes Software Market Size and Forecast (2019-2030)

7 Europe

7.1 Europe Diabetes Software Consumption Value by Type (2019-2030)
7.2 Europe Diabetes Software Consumption Value by Application (2019-2030)
7.3 Europe Diabetes Software Market Size by Country
- 7.3.1 Europe Diabetes Software Consumption Value by Country (2019-2030)
- 7.3.2 Germany Diabetes Software Market Size and Forecast (2019-2030)
- 7.3.3 France Diabetes Software Market Size and Forecast (2019-2030)
- 7.3.4 United Kingdom Diabetes Software Market Size and Forecast (2019-2030)
- 7.3.5 Russia Diabetes Software Market Size and Forecast (2019-2030)
- 7.3.6 Italy Diabetes Software Market Size and Forecast (2019-2030)

8 Asia-Pacific

8.1 Asia-Pacific Diabetes Software Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Diabetes Software Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Diabetes Software Market Size by Region
- 8.3.1 Asia-Pacific Diabetes Software Consumption Value by Region (2019-2030)
- 8.3.2 China Diabetes Software Market Size and Forecast (2019-2030)
- 8.3.3 Japan Diabetes Software Market Size and Forecast (2019-2030)
- 8.3.4 South Korea Diabetes Software Market Size and Forecast (2019-2030)
- 8.3.5 India Diabetes Software Market Size and Forecast (2019-2030)
- 8.3.6 Southeast Asia Diabetes Software Market Size and Forecast (2019-2030)
- 8.3.7 Australia Diabetes Software Market Size and Forecast (2019-2030)

9 South America

9.1 South America Diabetes Software Consumption Value by Type (2019-2030)
9.2 South America Diabetes Software Consumption Value by Application (2019-2030)
9.3 South America Diabetes Software Market Size by Country
- 9.3.1 South America Diabetes Software Consumption Value by Country (2019-2030)
- 9.3.2 Brazil Diabetes Software Market Size and Forecast (2019-2030)
- 9.3.3 Argentina Diabetes Software Market Size and Forecast (2019-2030)

10 Middle East & Africa

10.1 Middle East & Africa Diabetes Software Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Diabetes Software Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Diabetes Software Market Size by Country
- 10.3.1 Middle East & Africa Diabetes Software Consumption Value by Country (2019-2030)
- 10.3.2 Turkey Diabetes Software Market Size and Forecast (2019-2030)
- 10.3.3 Saudi Arabia Diabetes Software Market Size and Forecast (2019-2030)
- 10.3.4 UAE Diabetes Software Market Size and Forecast (2019-2030)

11 Market Dynamics

11.1 Diabetes Software Market Drivers
11.2 Diabetes Software Market Restraints
11.3 Diabetes Software Trends Analysis
11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

12.1 Diabetes Software Industry Chain
12.2 Diabetes Software Upstream Analysis
12.3 Diabetes Software Midstream Analysis
12.4 Diabetes Software Downstream Analysis

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology
14.2 Research Process and Data Source

Description

According to our (Global Info Research) latest study, the global Diabetes Software market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Diabetes software can include aggregate and analytical views of diabetes data. These views include:
– Calendar views that display glucose trends and compare them to patient’s insulin intake.
– Modal day views that display glucose trends and compare them to insulin intake on the same day of the week over time.
– Listing of contextual and lifestyle data such as patient’s carb intake.
– Insulin data that includes pie charts showing the ratio of basal to bolus rates.
– General data tables that show average blood glucose rates bucketed into different time periods
– And more.
More advanced diabetes software applications can include predictive insights. These insights can provide patients with alerts regarding their propensity to experience hyperglycemia or hypoglycemia events under certain conditions.
According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.
Global Use of Medicines 2023 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.
The Global Info Research report includes an overview of the development of the Diabetes Software industry chain, the market status of Type 1 Diabetes (For Smartphones, For Tablet PC), Type 2 Diabetes (For Smartphones, For Tablet PC), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Diabetes Software.
Regionally, the report analyzes the Diabetes Software markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Diabetes Software market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Diabetes Software market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Diabetes Software industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., For Smartphones, For Tablet PC).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Diabetes Software market.
Regional Analysis: The report involves examining the Diabetes Software market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Diabetes Software market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Diabetes Software:
Company Analysis: Report covers individual Diabetes Software players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Diabetes Software This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Type 1 Diabetes, Type 2 Diabetes).
Technology Analysis: Report covers specific technologies relevant to Diabetes Software. It assesses the current state, advancements, and potential future developments in Diabetes Software areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Diabetes Software market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Diabetes Software market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
For Smartphones
For Tablet PC
Web-based
Market segment by Application
Type 1 Diabetes
Type 2 Diabetes
Market segment by players, this report covers
Glooko
Accu-Chek (Roche)
Tidepool
LifeScan, Inc (Platinum Equity)
Pharmaco Diabetes
Ascensia Diabetes Care Holdings AG
Diabeto Medtech India Pvt. Ltd
Abbott Diabetes Care
Acon Diabetes Care International
BIONIME
Custo med
Dexcom
Dottli
GlucoMe
MyLife
Nova
Tandem Diabetes Care
Trividia Health
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Diabetes Software product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Diabetes Software, with revenue, gross margin and global market share of Diabetes Software from 2019 to 2024.
Chapter 3, the Diabetes Software competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Diabetes Software market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Diabetes Software.
Chapter 13, to describe Diabetes Software research findings and conclusion.

Buy now